Quick answer
Low-dose aspirin is now reserved mainly for people who have already had a heart attack, stroke or diagnosed artery disease, where its clot-preventing benefit outweighs the bleeding risk. Routine use to prevent a first heart attack is no longer recommended, because bleeding harm outweighs the benefit. Never start or stop aspirin without your doctor, especially around surgery or dental work.
Aspirin myths vs facts
MYTH Aspirin is harmless because you can buy it without a prescription.
Fact: Prescription status says nothing about safety. Aspirin raises the risk of major bleeding — stomach bleeds and brain bleeds — by roughly half in primary-prevention trials. It is a serious medicine that happens to be sold over the counter.
MYTH Enteric-coated ("gentle") aspirin cannot cause stomach ulcers.
Fact: The coating reduces local stomach irritation, but the ulcer and bleeding risk is mostly systemic: aspirin blocks COX-1 throughout the body, including the stomach lining's protective prostaglandins. Coated tablets still carry a meaningful bleeding risk.
MYTH If a little aspirin prevents clots, more aspirin prevents more clots.
Fact: The antiplatelet effect plateaus at low doses — once platelet COX-1 is blocked, there is nothing more to block. Higher doses do not add protection; they only add bleeding.
MYTH Everyone over 50 should take aspirin to prevent a first heart attack.
Fact: That was the old advice, and it has been substantially withdrawn. Trials including ARRIVE, ASCEND and ASPREE showed bleeding harm outweighing benefit for most people without established artery disease. Whether it suits you is an individual discussion with your doctor — age alone is not the criterion.
MYTH Pausing aspirin for a few days before surgery is always fine.
Fact: For people taking aspirin after a heart attack, stroke or stent, stopping — even briefly — raises the risk of another clotting event. Any pause around surgery or dental work must be planned with your doctor and surgeon, weighing clot risk against bleeding risk.
Antiplatelet drug classes compared
Aspirin is one of several drug classes that make platelets less sticky. This table compares the classes factually — which one suits a patient is a medical decision, not a shopping choice.
| Class | Examples | How it differs | Typical setting |
|---|---|---|---|
| Aspirin (COX-1 blocker) | Aspirin | Irreversibly blocks platelet COX-1 for the 7–10 day life of the platelet; the original antiplatelet | Long-term secondary prevention |
| P2Y12 inhibitors | Clopidogrel, ticagrelor, prasugrel | Block a different platelet activation pathway (the ADP receptor); often combined with aspirin after stents or acute coronary events | After stents, acute coronary syndrome |
| GP IIb/IIIa inhibitors | Abciximab, eptifibatide, tirofiban | Block the final common pathway of platelet clumping; given intravenously | Hospital use during acute cardiac procedures |
| Dipyridamole | Dipyridamole | Older agent that raises platelet cAMP; sometimes paired with aspirin in stroke prevention in some regions | Selected stroke-prevention regimens |
Primary vs secondary prevention
The distinction decides whether aspirin helps or harms:
| Type | Meaning | What the evidence shows |
|---|---|---|
| Primary prevention | No previous heart attack or stroke | Generally not advised: bleeding risk outweighs benefit for most people |
| Secondary prevention | Previous heart attack, stroke, or stent | Strongly supported: benefit clearly exceeds bleeding risk |
| Peripheral artery disease | Known narrowing of leg arteries | Supported as secondary prevention |
| High-risk surgery patients | Discuss with surgeon | Individual decision balancing clot vs bleeding risk |
Why the advice on primary prevention changed
For decades low-dose aspirin was widely recommended to healthy adults to prevent a first heart attack. That advice has been substantially withdrawn. A 2019 systematic review identified 20 randomised controlled trials of aspirin for primary prevention; a pooled analysis of 10 of these trials, involving 144,930 individuals without established cardiovascular disease, found that aspirin reduced the risk of non-fatal heart attack by 21%, but had no statistically significant effect on cardiovascular death and increased the risk of major bleeding by 48%.2 This includes the ARRIVE, ASCEND, and ASPREE trials.
A separate pooled analysis of 4 trials involving 20,326 individuals with diabetes found aspirin had no benefit on heart attack or cardiovascular death, yet still increased bleeding by 49%. Several guidelines now advise against routine aspirin for primary prevention, particularly over the age of 70, and recommend an individual discussion where risk is high and bleeding risk is low.
The mechanism behind the bleeding risk is pharmacological. Aspirin irreversibly inhibits COX-1, the enzyme platelets use to make thromboxane A2, a clotting signal. Since platelets have no nucleus, they cannot regenerate COX-1, so the inhibition lasts the full 7–10 day platelet lifespan. The same COX-1 pathway in the stomach lining makes prostaglandins that protect against ulceration, and blocking it there raises the risk of gastric erosion and bleeding, independent of any antiplatelet effect.
The picture is quite different in secondary prevention. In people who have already had a heart attack, ischaemic stroke, or who have known coronary or peripheral arterial disease, the benefit clearly exceeds the bleeding risk and aspirin remains standard long-term therapy. If you are taking aspirin and are not sure which category applies to you, that is a worthwhile question to raise, because the answer determines whether continuing is appropriate.
Reducing the bleeding risk
- Stomach protection: a proton pump inhibitor (such as omeprazole) substantially reduces gastrointestinal bleeding and is recommended for those at higher risk, including older adults and anyone with previous ulcer disease. Ask your doctor whether you should take both.
- Avoid concurrent NSAIDs: ibuprofen and similar drugs multiply the ulcer risk; ibuprofen also interferes with aspirin's antiplatelet effect when taken shortly before it.
- Limit alcohol, which independently raises gastrointestinal bleeding risk.
- Testing and treating Helicobacter pylori in those with ulcer history before long-term therapy.
Aspirin in people with diabetes: the ASCEND trial
People with diabetes have a significantly elevated cardiovascular risk, which makes the primary prevention question particularly pressing for this group. The ASCEND trial, a randomised controlled trial specifically designed to address it, randomly assigned 15,480 adults with diabetes and no prior cardiovascular disease to daily aspirin or placebo, and followed them for an average of 7.4 years.3
Aspirin prevented some serious vascular events but caused a similar number of major bleeds — the benefit and harm were finely balanced, which is why routine aspirin for primary prevention is not recommended even in diabetes. The decision is individual, weighing personal clotting risk against bleeding risk with your doctor.
Around surgery and dental work
Tell your dentist and every doctor that you take daily aspirin. Whether it is paused before a procedure depends on the balance between clotting risk (why you take it) and bleeding risk (what the procedure involves) — plan any pause with your doctor in advance, and never stop on your own.
Warning signs while taking it
Report promptly: black or tarry stools, blood in urine or vomit, unusual or large bruises, nosebleeds that will not stop, or a severe headache unlike any before (a possible sign of bleeding). These can signal significant bleeding even when you feel otherwise well.
Pharmacist's practical notes
Aspirin therapy does not usually require routine blood tests, but it does need vigilance for bleeding. Watch for warning signs such as unusual bruising, nosebleeds that are hard to stop, blood in the urine or stool, black or tarry stools, or vomit that looks like coffee grounds, and report any of these to your doctor promptly. Your doctor may still order periodic blood counts or kidney checks depending on your other medicines and conditions.
Tell your doctor and pharmacist about every other medicine you take, because several common ones raise bleeding risk when combined with aspirin: other blood thinners, antiplatelet medicines, regular NSAID painkillers such as ibuprofen, and some antidepressants. Alcohol also increases the risk of stomach irritation and bleeding. Keep a single updated medicine list and show it at every appointment, including before dental work.
Aspirin protects against clots only while you keep taking it, so a missed dose matters more than with many medicines — but never double up; ask your pharmacist what to do after a missed dose. Store tablets in a cool, dry place; enteric-coated aspirin can break down in moisture, and tablets that smell strongly of vinegar should be replaced. Keep track of refills so therapy is never interrupted without your doctor’s knowledge.
Tell every surgeon, dentist, and proceduralist that you take aspirin well before any planned procedure, because it is often discussed whether to pause it — and that decision belongs to your doctor, balancing clot risk against bleeding risk. Carry a medicine list or card in your wallet, and make sure a family member knows you take it, in case of an emergency.
In India
Aspirin is among the cheapest medicines in India; generic versions are typically inexpensive, though prices vary by brand and city.
It is widely available at pharmacies across India, including the doses used for heart protection. Although it is often sold without a prescription, aspirin for heart protection should only be started, stopped, or paused on a doctor’s advice. Follow your own prescription; never start, stop, or change a dose without your doctor.
Frequently Asked Questions
Can I stop aspirin if I don't want to take it?
Does aspirin prevent cancer?
Which aspirin dose is best?
Aspirin gives me heartburn — what should I do?
What painkiller can I take for a headache while on aspirin therapy?
Should I carry something showing I take aspirin?
I forgot yesterday’s aspirin — should I take two today?
References
The clinical information on this page is drawn from peer-reviewed sources indexed by the US National Library of Medicine. Links go to the source so you can read it yourself.
- Salicylic Acid (Aspirin). In: StatPearls. Treasure Island (FL): StatPearls Publishing. NCBI Bookshelf NBK519032
- Christiansen M, Grove EL, Hvas AM. Primary Prevention of Cardiovascular Events with Aspirin: Toward More Harm than Benefit, A Systematic Review and Meta-Analysis. Semin Thromb Hemost. 2019;45(5):478–489. PMID 31096304 · doi:10.1055/s-0039-1687905
- ASCEND Study Collaborative Group; Bowman L, Mafham M, et al. Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus. N Engl J Med. 2018;379(16):1529–1539. PMID 30146931 · doi:10.1056/NEJMoa1804988
Related reading
- Dengue FeverWhat are the symptoms of dengue fever? Learn about dengue NS1 antigen…
- Warfarin & INR: Complete Patient GuideComplete warfarin guide: what INR means, target ranges for different…
- Aplastic AnaemiaWhat is aplastic anaemia? Learn how blood tests diagnose bone marrow…
- Blood Tests Before SurgeryWhich blood tests are done before an operation? Learn about CBC…
- Omeprazole (PPI): Complete Patient GuideComplete guide to omeprazole (Losec/Prilosec) for acid reflux, GERD and…
- CD4 Count (T-Cell Count)What is a normal CD4 count? Learn how CD4 T-cell counts track HIV…